How Important are Client Characteristics to Understanding Treatment Process in the Therapeutic Community?

References

• Hubbard R L, Craddock S G, Flynn P M, Anderson J, Etheridge R M. Overview of 1‐year follow‐up outcomes in the drug abuse treatment outcomes study (DATOS). Psychol Addict Behav 1997; 11(4)261–278, [CSA]
   Web of Science ®Google Scholar
• Simpson D D, Joe G W, Broome K M, Hiller M L, Knight K, Rowan‐Szal G A. Program diversity and treatment retention rates in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav 1997; 11: 279–293, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Messina N, Wish E, Nemes S. Predictors of treatment outcomes in men and women admitted to a therapeutic community. Am J Drug Alcohol Abuse 2000; 26(2)207–227, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Troumbourou J W, Hamilton M, Fallon B. Treatment level progress and time spent in treatment in the prediction of outcomes following drug‐free therapeutic community treatment. Addiction 1998; 93(7)1051–1064, [CROSSREF]
   PubMedGoogle Scholar
• Moos R H, Moos B S, Andrassy J M. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatr Serv 1999; 50: 1577–1583, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jainchill N, Hawke J, De Leon G, Yagelka J. Adolescents in therapeutic communities: one‐year post‐treatment outcomes. J Psychoact Drugs 2000; 32(1)81–94, [CSA]
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (U.S.). Medicare: A Strategy for Quality Assurance. National Academy Press, Washington, D.C. 1990; Vol. 1: 4
   Google Scholar
• Etheridge R M, Hubbard R L. Conceptualizing and assessing treatment structure and process in community‐based drug dependency treatment programs. Subst Use Misuse 2000; 35: 1757–1795, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hubbard R L, Marsden M E, Rachal J V, Harwood H J, Cavanaugh E R, Ginzburg H M. Drug Abuse Treatment: A National Study of Effectiveness. University of North Carolina Press, Chapel Hill, NC 1989
   Google Scholar
• Donabedian A. Explorations in Quality Assessment and Monitoring: The Definition of Quality and Approaches to Its Assessment. Health Administration Press, Ann Arbor, MI 1980; Vol. 1.
   Google Scholar
• Donabedian A. Explorations in Quality Assessment and Monitoring: The Definition of Quality and Approaches to Its Assessment. Health Administration Press, Ann Arbor, MI 1982; Vol. 2
   Google Scholar
• Donabedian A. Explorations in Quality Assessment and Monitoring: The Definition of Quality and Approaches to Its Assessment. Health Administration Press, Ann Arbor, MI 1984; Vol. 3
   Google Scholar
• Donabedian A. Monitoring: the eyes and ears of healthcare. Health Progr 1988; 69: 38–43
   PubMedGoogle Scholar
• Donabedian A. Quality assessment and assurance: unit of purposes, diversity of means. Inquiry 1988; 25: 173–192, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Donabedian A. The quality of care: how can it be assessed?. JAMA 1988; 260: 1743–1748, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hammermeister K E, Shroyer A L, Sethi G K, Grover F L. Why it is important to demonstrate linkages between outcomes of care and process and structures of care. Med Care 1995; 33: OS5–OS16, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McGlynn E A, Norquist G S, Wells K B, Sullivan G, Liberman R P. Quality‐of‐care research in mental health: responding to the challenge. Inquiry 1988; 25: 157–170, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Burnam M A. Measuring Outcomes of Care For Substance Use and Mental Disorders, RP‐612. RAND, Santa Monica, CA 1997, (Reprinted from New Dir Ment Health Serv 1996; 71; 3–17)
   Google Scholar
• Phibbs C S, Swindle R W, Recine B. Does case mix matter for substance abuse treatment? A comparison of observed and case‐mix adjusted readmission rates for inpatient substance abuse treatment in the department of veterans affairs. Health Serv Res 1997; 31: 755–771, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Peterson K A, Swindle R W, Phibbs C S, Recine B, Moos R F. Determinants of readmission following inpatient substance abuse treatment: a national study of VA programs. Med Care 1994; 32: 535–550, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Melnick G, De Leon G, Hawke J, Jainchill N, Kressel D. Motivation and readiness for therapeutic community treatment among adolescents and adult substance abusers. Am J Drug Alcohol Abuse 1997; 23(4)485–506, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hser Y I, Grella C E, Hsieh S C, Anglin M D, Brown B S. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend 1999; 57: 137–150, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hser Y I, Joshi V, Anglin M D, Fletcher B. Predicting posttreatment cocaine abstinence for first‐time admissions and treatment repeaters. Am J Public Health 1999; 89: 666–671, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• De Leon G. Therapeutic communities: is there an essential model?. Community as Method: Therapeutic Communities for Special Population and Special Settings, G De Leon. Praeger, Westport, CT 1997; 3–18
   Google Scholar
• Wenzel S L, Ebener P A, Farley D. Building a Client Level Process and Outcomes Monitoring System. Final report to the Phoenix House Foundation, RAND, Santa Monica, CA 1998
   Google Scholar
• Orlando M, Wenzel S, Ebener P, Edwards M, Mandell W. The dimension of change instrument (DCI): a treatment process measure for therapeutic community, Under review
   Google Scholar
• Wenzel S L, Orlando M. Quality of Care in the Therapeutic Community, R01 DA 14969. National Institute on Drug Abuse, Rockville, MD 2001
   Google Scholar
• Fink A, Kosecoff J, Chassin M, Brook R H. Consensus Methods: Characteristics and Guidelines for Use, N‐3367‐HHS. RAND, Santa Monica, CA 1991
   Google Scholar
• Prochaska J O, DiClemente C C, Norcross J C. In search of how people change: applications to addictive behaviors. Am Psychol 1992; 47(9)1102–1114, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Leon G, Melnick G, Kressel D. Motivation and treatment readiness for therapeutic community treatment among cocaine and other drug abusers. Am J Drug Alcohol Abuse 1997; 23: 169–189, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Joe G W, Simpson D D, Broome K M. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998; 93(8)1177–1190, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Melnick G, De Leon G, Thomas G, Kressel D, Wexler H K. Treatment process in prison therapeutic communities: motivation, participation, and outcome. Am J Drug Alcohol Abuse 2001; 27(4)633–650, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Winick C. Maturing out of narcotic addiction. Bull Narcot 1962; 14: 1–7
   Google Scholar
• Ramsey M L. Special features and treatment needs of female drug offenders. J Offend Counsel Serv Rehab 1980; 4(4)357–368
   Google Scholar
• Peugh J, Belenko S. Substance‐involved women inmates: challenges to providing effective treatment. Prison J 1999; 79(1)23–44
   Google Scholar
• Levy S J, Doyle K M. Attitude toward women in a drug treatment program. J Drug Issues 1974; 4(4)428–435
   Web of Science ®Google Scholar
• Hughes P H, Coletti S D, Neri R L, Urmann C F, Stahl S, Sicilian D M, Anthony J C. Retaining cocaine‐abusing women in a therapeutic community: the net effect of a child live‐in program. Am J Public Health 1995; 85(8)1149–1152, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• De Leon G, Jainchill N. Male and female drug abusers: social and psychological status 2 years after treatment in a therapeutic community. Am J Drug Alcohol Abuse 1981; 8(4)465–497, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fiorentine R, Anglin M D, Gil‐Rivas V, Taylor E. Drug treatment: explaining the gender paradox. Subst Use Misuse 1997; 32(6)653–678, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Comfort M, Sockloff A, Loverro J, Kaltenbach K. Multiple predictors of substance‐abusing women's treatment and life outcomes: a prospective longitudinal study. Addict Behav 2003; 28: 199–224, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Coletti S D, Schinka J A, Hughes P H, Hamilton N L, Renard C G, Sicilian D M, Neri R L. Specialized therapeutic community treatment for chemically dependent women and their children. Community as Method: Therapeutic Communities for Special Population and Special Settings, G De Leon. Praeger, Westport, CT 1997; 115–128
   Google Scholar
• Stevens S J, Arbiter N, McGrath R. Women and children: therapeutic community substance abuse treatment. Community as Method: Therapeutic Communities for Special Population and Special Settings, G De Leon. Praeger, Westport, CT 1997; 129–141
   Google Scholar